Answers are grounded in this paper and cite their sources.
TO THE EDITOR: Acute myeloid leukemia (AML) is a heterogeneous disease for which genetic profiles dictate clinical outcomes. Cytogenetic and molecular profiling in AML is a mandatory diagnostic and prognostic requirement, yet interpretation of these results is becoming increasingly complex. Next
No takes yet. Share an insight, caveat, or question.
Straube et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: